Insufficient scRNA-seq data for expression of TRIB3 at single-cell level.
Insufficient scRNA-seq data for expression of TRIB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 2509.32 | 1808 / 1809 | 99% | 86.66 | 468 / 472 |
liver | 100% | 5016.08 | 226 / 226 | 97% | 83.07 | 395 / 406 |
prostate | 98% | 930.76 | 240 / 245 | 98% | 46.45 | 494 / 502 |
breast | 98% | 950.98 | 448 / 459 | 97% | 58.22 | 1084 / 1118 |
lung | 99% | 1993.08 | 573 / 578 | 88% | 47.49 | 1021 / 1155 |
pancreas | 100% | 1084.07 | 328 / 328 | 78% | 24.33 | 139 / 178 |
adrenal gland | 100% | 1688.94 | 257 / 258 | 70% | 27.21 | 161 / 230 |
stomach | 87% | 786.25 | 313 / 359 | 81% | 61.46 | 232 / 286 |
kidney | 87% | 627.46 | 77 / 89 | 77% | 47.93 | 697 / 901 |
intestine | 68% | 376.71 | 655 / 966 | 95% | 80.19 | 499 / 527 |
bladder | 71% | 526.71 | 15 / 21 | 87% | 55.37 | 439 / 504 |
esophagus | 71% | 874.39 | 1032 / 1445 | 86% | 42.84 | 158 / 183 |
ovary | 81% | 316.52 | 145 / 180 | 76% | 26.11 | 326 / 430 |
uterus | 71% | 308.42 | 121 / 170 | 81% | 36.30 | 372 / 459 |
thymus | 99% | 789.32 | 645 / 653 | 51% | 31.61 | 311 / 605 |
brain | 63% | 315.95 | 1669 / 2642 | 61% | 18.29 | 428 / 705 |
spleen | 100% | 1371.88 | 241 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 31.57 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 96% | 26.11 | 77 / 80 |
adipose | 96% | 764.41 | 1158 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 918.66 | 799 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 26.09 | 34 / 45 |
blood vessel | 58% | 267.75 | 769 / 1335 | 0% | 0 | 0 / 0 |
heart | 33% | 209.90 | 288 / 861 | 0% | 0 | 0 / 0 |
muscle | 14% | 66.86 | 111 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0051443 | Biological process | positive regulation of ubiquitin-protein transferase activity |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0010506 | Biological process | regulation of autophagy |
GO_0043405 | Biological process | regulation of MAP kinase activity |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0010827 | Biological process | regulation of glucose transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0031434 | Molecular function | mitogen-activated protein kinase kinase binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0055106 | Molecular function | ubiquitin-protein transferase regulator activity |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TRIB3 |
Protein name | Tribbles homolog 3 (TRB-3) (Neuronal cell death-inducible putative kinase) (SINK) (p65-interacting inhibitor of NF-kappa-B) Tribbles pseudokinase 3 |
Synonyms | SKIP3 C20orf97 TRB3 NIPK |
Description | FUNCTION: Inactive protein kinase which acts as a regulator of the integrated stress response (ISR), a process for adaptation to various stress . Inhibits the transcriptional activity of DDIT3/CHOP and is involved in DDIT3/CHOP-dependent cell death during ER stress . May play a role in programmed neuronal cell death but does not appear to affect non-neuronal cells . Acts as a negative feedback regulator of the ATF4-dependent transcription during the ISR: while TRIB3 expression is promoted by ATF4, TRIB3 protein interacts with ATF4 and inhibits ATF4 transcription activity (By similarity). Disrupts insulin signaling by binding directly to Akt kinases and blocking their activation (By similarity). May bind directly to and mask the 'Thr-308' phosphorylation site in AKT1 (By similarity). Interacts with the NF-kappa-B transactivator p65 RELA and inhibits its phosphorylation and thus its transcriptional activation activity . Interacts with MAPK kinases and regulates activation of MAP kinases . Can inhibit APOBEC3A editing of nuclear DNA . . |
Accessions | Q96RU7 A0A087WTX3 ENST00000422053.3 J3KR25 B0QYQ2 ENST00000615226.4 ENST00000449710.5 ENST00000217233.9 |